4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-fluoro-2-methylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-fluoro-2-methylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-fluoro-2-methylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
Compound ID: | L310-3325 |
Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-fluoro-2-methylphenyl)-6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
Molecular Weight: | 486.52 |
Molecular Formula: | C23 H23 F N4 O5 S |
Smiles: | Cc1cc(ccc1NS(c1cc2c(cc1C)N(Cc1nc(C3CCC3)on1)C(CO2)=O)(=O)=O)F |
Stereo: | ACHIRAL |
logP: | 3.4541 |
logD: | 3.1744 |
logSw: | -3.8579 |
Hydrogen bond acceptors count: | 10 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 97.211 |
InChI Key: | ADUFQNRPFBZIKD-UHFFFAOYSA-N |